CEO, Phosphorus Inc
Biography
Alexander Bisignano is responsible for setting strategy and vision for Phosphorus, a full-stack genomics as a service company. Before Phosphorus, Alex co-founded Recombine, a clinical genetic testing company, which was acquired by CooperSurgical in May of 2016 for $85M. At Phosphorus and Recombine Alex developed novel genotyping and next-generation sequencing assays for clinical genetics. His work has been presented at the American Society for Reproductive Medicine, the European Society for Human Reproduction and Embryology, the National Lipid Association Annual Meeting, the American Society of Human Genetics and a number of other scientific programs. Alex has also appeared on Fox Business and Bloomberg TV as an expert in the genetic testing market. Alex received his A.B. in molecular biology from Princeton University and is a member of Sigma Xi, the Scientific Research Society.
Genomic Profiling Showcase:
Phosphorus Inc
Phosphorus is a leader in clinical-grade testing at scale. From provider genetics solutions to highly accurate COVID-19 testing, we provide the technology, infrastructure, and expertise to drive care initiatives. We work with physicians, healthcare organizations, employers, and practices to improve health outcomes.
Beyond ACMG 73: The Quantified Impact of Population-based Comprehensive Screening for Genetic Conditions and Susceptibilities
